Array
(
[id] => 1721
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1721.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => When using LMWH for thromboprophylaxis, we suggest against monitoring anti-Xa levels for dosing adjustment.（Evidence level:moderate/Low；Recommendation grade:weak）
[laiyuan] => 在使用低分子量肝素进行血栓预防时，我们建议不要通过监测抗Xa水平来调整剂量。（证据分级：中或低；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在使用低分子量肝素进行血栓预防时，我们建议不要通过监测抗Xa水平来调整剂量。（证据分级：中或低；推荐强度：弱推荐）
When using LMWH for thromboprophylaxis, we suggest against monitoring anti-Xa levels for dosing adjustment.（Evidence level:moderate/Low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1722
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1722.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest adjusting LMWH dosing in patients with low body weight, in those with class III or greater obesity, and in patients with severe renal impairment.（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 我们建议对体重偏低、患有Ⅲ级及以上肥胖以及重度肾功能损害的患者调整低分子量肝素的给药剂量。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议对体重偏低、患有Ⅲ级及以上肥胖以及重度肾功能损害的患者调整低分子量肝素的给药剂量。（证据分级：中或低；推荐强度：强推荐）
We suggest adjusting LMWH dosing in patients with low body weight, in those with class III or greater obesity, and in patients with severe renal impairment.（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1723
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1723.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => In cases of end-stage renal disease (eGFR < 15 mL/min/1.73 m²), we recommend using UFH at a dose of 5000 IU x 2/day subcutaneously. （Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 对于稳定的重度肾功能损害患者（估算的肾小球滤过率在15 至30mL/min/1.73 m²之间），我们推荐使用普通肝素，皮下注射，剂量为每日两次，每次5000IU。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于稳定的重度肾功能损害患者（估算的肾小球滤过率在15 至30mL/min/1.73 m²之间），我们推荐使用普通肝素，皮下注射，剂量为每日两次，每次5000IU。（证据分级：高；推荐强度：强推荐）
In cases of end-stage renal disease (eGFR < 15 mL/min/1.73 m²), we recommend using UFH at a dose of 5000 IU x 2/day subcutaneously. （Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1724
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1724.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => For patients with stable severe renal impairment (estimated GFR between 15 and 30 mL/min/1.73 m²), we suggest using LMWH over UFH, according to the dosing regimens indicated by the marketing authorization:- enoxaparin 2000 IU x 1 subcutaneously per day if eGFR is from 15 to 30 mL/min/1.73 m²-tinzaparin 4500 IU x 1 subcutaneously per day if eGFR is > 20 mL/min/1.73 m²（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 对于稳定的重度肾功能损害患者（估算的肾小球滤过率在15 至30mL/min/1.73 m²之间），我们建议根据上市许可所标明的给药方案，优先使用低分子量肝素而非普通肝素：如果估算的肾小球滤过率在15至30mL/min/1.73 m²之间，依诺肝素皮下注射，每日一次，每次2000IU；如果肾小球滤过率大于 20 mL/min/1.73 m²，亭扎肝素皮下注射，每次4500IU，每日一次。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于稳定的重度肾功能损害患者（估算的肾小球滤过率在15 至30mL/min/1.73 m²之间），我们建议根据上市许可所标明的给药方案，优先使用低分子量肝素而非普通肝素：如果估算的肾小球滤过率在15至30mL/min/1.73 m²之间，依诺肝素皮下注射，每日一次，每次2000IU；如果肾小球滤过率大于 20 mL/min/1.73 m²，亭扎肝素皮下注射，每次4500IU，每日一次。（证据分级：中或低；推荐强度：强推荐）
For patients with stable severe renal impairment (estimated GFR between 15 and 30 mL/min/1.73 m²), we suggest using LMWH over UFH, according to the dosing regimens indicated by the marketing authorization:- enoxaparin 2000 IU x 1 subcutaneously per day if eGFR is from 15 to 30 mL/min/1.73 m²-tinzaparin 4500 IU x 1 subcutaneously per day if eGFR is > 20 mL/min/1.73 m²（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1725
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1725.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommended against the routine combination of IPC with pharmacological prophylaxis.（Evidence level:High；Recommendation grade:weak）
[laiyuan] => 我们不建议常规将间歇性充气加压装置与药物预防措施相结合。（证据分级：高；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们不建议常规将间歇性充气加压装置与药物预防措施相结合。（证据分级：高；推荐强度：弱推荐）
We recommended against the routine combination of IPC with pharmacological prophylaxis.（Evidence level:High；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1726
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1726.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend IPC when prophylactic anticoagulants are contraindicated, particularly in situations with a high risk of bleeding.（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 当预防性抗凝剂存在禁忌证时，特别是在高出血风险的情况下，我们建议使用间歇性充气加压装置。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
当预防性抗凝剂存在禁忌证时，特别是在高出血风险的情况下，我们建议使用间歇性充气加压装置。（证据分级：高；推荐强度：强推荐）
We recommend IPC when prophylactic anticoagulants are contraindicated, particularly in situations with a high risk of bleeding.（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1727
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1727.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against Graduated Compression Stockings for venous thromboprophylaxis, regardless of the risk for VTE.（Evidence level:High；Recommendation grade:weak）
[laiyuan] => 我们不建议使用梯度压力袜进行静脉血栓预防，无论静脉血栓栓塞症的风险多大。（证据分级：高；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们不建议使用梯度压力袜进行静脉血栓预防，无论静脉血栓栓塞症的风险多大。（证据分级：高；推荐强度：弱推荐）
We recommend against Graduated Compression Stockings for venous thromboprophylaxis, regardless of the risk for VTE.（Evidence level:High；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1728
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1728.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend that the administration of tranexamic acid should not modify the regimen of perioperative venous thromboprophylaxis. （Evidence level:High；Recommendation grade:weak）
[laiyuan] => 我们建议氨甲环酸的使用不应改变围手术期静脉血栓预防的方案。（证据分级：高；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议氨甲环酸的使用不应改变围手术期静脉血栓预防的方案。（证据分级：高；推荐强度：弱推荐）
We recommend that the administration of tranexamic acid should not modify the regimen of perioperative venous thromboprophylaxis. （Evidence level:High；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1729
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1729.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest not measuring anti-Xa levels during thromboprophylaxis with LMWH.（Evidence level:moderate/Low；Recommendation grade:weak）
[laiyuan] => 我们建议在使用低分子量肝素进行血栓预防期间不要测量抗 Xa水平。（证据分级：中或低；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议在使用低分子量肝素进行血栓预防期间不要测量抗 Xa水平。（证据分级：中或低；推荐强度：弱推荐）
We suggest not measuring anti-Xa levels during thromboprophylaxis with LMWH.（Evidence level:moderate/Low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1730
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1730.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:01
[updatetime] => 2024-12-12 11:19:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest not measuring anticoagulation levels for patients with extreme body weights and those with renal impairment (refer to the dedicated sections).（Evidence level:moderate/Low；Recommendation grade:weak）
[laiyuan] => 我们建议对于体重极端（过高或过低）以及存在肾功能损害的患者（具体可参考相关专门章节），不要测量抗凝水平。（证据分级：中或低；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973541
[_updatetime] => 1733973541
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议对于体重极端（过高或过低）以及存在肾功能损害的患者（具体可参考相关专门章节），不要测量抗凝水平。（证据分级：中或低；推荐强度：弱推荐）
We suggest not measuring anticoagulation levels for patients with extreme body weights and those with renal impairment (refer to the dedicated sections).（Evidence level:moderate/Low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
